SelectQuote, Inc. (SLQT) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SLQT currently has 189M outstanding shares. with limited dilution risk as only 27.6M additional shares (14.6%) are authorized for issuance. The company has diluted shareholders by 13.92% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 05, 2026 |
10-Q filing | 189.5M shares outstanding |
190M | 28M |
| Nov 06, 2025 |
10-Q filing | 185.8M shares outstanding |
190M | 28M |
| Aug 21, 2025 |
10-K filing | 176.1M shares outstanding |
180M | 28M |
| May 12, 2025 |
10-Q filing | 178.2M shares outstanding |
180M | 28M |
| Feb 28, 2025 |
8-K filing: SelectQuote, Inc. completed the sale of 350,000 shares of Senior Non-Convertible Preferred Stock and 30,833,333 warrants to NL Monarch Holdings LLC (Morgan Stanley) and NL Monarch Holdings II LLC (Bain) for an aggregate investment of $350,000,000. ($350.0M proceeds) |
170M | 28M |
| Feb 10, 2025 |
10-Q filing | 171.8M shares outstanding |
170M | 28M |
| Feb 10, 2025 |
8-K filing: SelectQuote, Inc. entered into Senior Preferred Stock Purchase Agreements with NL Monarch Holdings LLC (Morgan Stanley) and NL Monarch Holdings II LLC (Bain) for an aggregate investment of $350,000,000 in exchange for 350,000 shares of Senior Non-Convertible Preferred Stock and warrants to purchase 30,833,333 shares of common stock. The company also amended its Credit Agreement. ($350.0M proceeds) |
170M | 28M |
| Nov 04, 2024 |
10-Q filing | 170.4M shares outstanding |
170M | 28M |
| Oct 16, 2024 |
8-K filing: SelectQuote, Inc. issued warrants to purchase 5,568,360 shares of common stock to certain existing lenders. |
170M | 28M |
| Sep 13, 2024 |
10-K filing | 168.5M shares outstanding |
170M | 28M |
| May 09, 2024 |
10-Q filing | 169.1M shares outstanding |
170M | 28M |
| Feb 08, 2024 |
10-Q filing | 168.3M shares outstanding |
170M | 28M |
| Nov 03, 2023 |
10-Q filing | 167.5M shares outstanding |
170M | 28M |
| Sep 13, 2023 |
10-K filing | 166.1M shares outstanding |
170M | 28M |
| May 10, 2023 |
10-Q filing | 166.5M shares outstanding |
170M | 28M |
| Feb 07, 2023 |
10-Q filing | 166.5M shares outstanding |
170M | 28M |
| Nov 03, 2022 |
10-Q filing | 164.8M shares outstanding |
160M | 28M |
| Aug 29, 2022 |
10-K filing | 164.0M shares outstanding |
160M | 28M |
| May 05, 2022 |
10-Q filing | 164.1M shares outstanding |
160M | 28M |
| Feb 14, 2022 |
10-Q filing | 164.0M shares outstanding |
160M | 28M |
| Nov 05, 2021 |
10-Q filing | 163.7M shares outstanding |
160M | 28M |
| Aug 26, 2021 |
10-K filing | 162.9M shares outstanding |
160M | 28M |
| May 12, 2021 |
10-Q filing | 163.0M shares outstanding |
160M | 28M |
| Mar 01, 2021 |
S-1 filing: S-1 filing for a public offering of 10,600,000 shares of common stock by selling stockholders, with an option for underwriters to purchase an additional 1,590,000 shares. |
160M | 28M |
| Feb 08, 2021 |
10-Q filing | 162.6M shares outstanding |
160M | 15M |
| Nov 06, 2020 |
10-Q filing | 162.4M shares outstanding |
160M | 15M |
| Sep 10, 2020 |
10-K filing | 162.6M shares outstanding |
160M | 15M |
| May 19, 2020 |
S-1/A filing: This is an S-1/A filing detailing recent sales of unregistered securities, including issuances of Series E preferred stock, grants of options to purchase common stock, and issuances of common stock upon the exercise of stock options. |
160M | 15M |
| May 15, 2020 |
S-1/A filing: This S-1/A filing outlines an offering of common stock by both the company and selling stockholders, with underwriters having an option to purchase additional shares. |
160M | 29M |
| Mar 05, 2020 |
S-1/A filing: This S-1/A filing from SelectQuote, Inc. includes information about a proposed offering of common stock by the company and selling stockholders, with an option for underwriters to purchase additional shares, and details regarding the use of proceeds, potential conflicts of interest, dividend policy, and risk factors. |
140M | 0 |